开发用于斑秃的Scap Hair Assessment PRO™测量工具
本研究基于10名临床专家意见开发斑秃头皮毛发评估PRO™工具,并通过两轮半结构化定性访谈(第1轮成人25例、青少年5例;第2轮成人15例)对≥50%头皮脱发患者进行认知调试与修改。结果显示患者能使用百分比自报当前头皮毛发量,并确认五级反应量表(无脱发0%、有限1-20%、中度21-49%、大量50-94%、几乎全部/全部95-100%)可评估头皮脱发;几乎所有患者认为治疗成功为毛发再生致头皮脱发≤20%。结论认为该PRO™是内容有效、临床有意义的斑秃头皮脱发分级评估工具。
要点
- PRO™工具包含五级脱发分级,与AA-IGA™五级反应水平可比。
- 患者可自报头皮毛发百分比,支持使用五级量表评估脱发。
- 几乎所有患者将≤20%头皮脱发视为治疗成功。
核心结论
- Scap Hair Assessment PRO™是内容有效、临床有意义的斑秃头皮脱发分级评估工具,适用于基线≥50%头皮脱发的患者。
研究设计与样本
- 基于10名斑秃临床专家意见开发PRO™草案,并通过两轮半结构化定性访谈对患者进行认知调试、修改与定稿。
- 第1轮访谈成人25例、15-17岁青少年5例;第2轮访谈成人15例,均为北美≥50%头皮脱发患者。
主要发现
- 所有患者均将头皮脱发列为斑秃关键体征或症状,并能使用百分比自报当前头皮毛发量。
- 第1轮中并非所有患者对测量概念解读一致,修改后第2轮患者无困难完成PRO™。
- 患者确认可使用五级反应量表(无脱发0%、有限1-20%、中度21-49%、大量50-94%、几乎全部/全部95-100%)评估头皮脱发。
- 几乎所有患者认为毛发再生致头皮脱发≤20%为治疗成功。
关键数值与推荐
- PRO™五级反应量表:无脱发0%;有限1-20%;中度21-49%;大量50-94%;几乎全部或全部95-100%。
- 患者判定治疗成功:毛发再生致头皮脱发≤20%。
临床怎么用
- 该PRO™可用于评估基线≥50%头皮脱发斑秃患者的治疗反应,以五级量表记录头皮脱发百分比分级。
局限性
- 研究仅纳入北美患者,样本量有限(第1轮成人25例、青少年5例;第2轮成人15例),未报告信效度等心理测量学验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Valid patient-reported outcome (PRO) measures are required to evaluate alopecia areata (AA) treatments. OBJECTIVES: To develop a content-valid and clinically meaningful PRO measure to assess AA scalp hair loss with scores comparable with the five-response-level Alopecia Areata Investigator Global Assessment (AA-IGA™). METHODS: A draft PRO measure was developed based on input from 10 clinical experts in AA. The PRO measure was cognitively debriefed, modified and finalized through two rounds of qualitative semistructured interviews with patients with AA who had experienced ≥ 50% scalp hair loss. Data were thematically analysed. RESULTS: Adults (round 1: n = 25; round 2: n = 15) and adolescents aged 15-17 years (round 1: n = 5) in North America participated. All patients named scalp hair loss as a key AA sign or symptom. Patients demonstrated the ability to self-report their current amount of scalp hair using percentages. In round 1 not all patients interpreted the measurement concept consistently; therefore, the PRO was modified to clarify the measurement concept to improve usability. Following modifications, patients in round 2 responded without difficulty to the PRO measure. Patients confirmed that they could use the five-level response scale to rate their scalp hair loss: no missing hair, 0%; limited, 1-20%; moderate, 21-49%; large, 50-94%; nearly all or all, 95-100%. Almost all patients deemed hair regrowth resulting in ≤ 20% scalp hair loss a treatment success. CONCLUSIONS: The Scalp Hair Assessment PRO™ is a content-valid, clinically meaningful assessment of distinct gradations of scalp hair loss for evaluating AA treatment for patients with ≥ 50% hair loss at baseline.
引用
- Wyrwich KW, Kitchen H, Knight S, et al. Development of the Scalp Hair Assessment PRO™ measure for alopecia areata. Br J Dermatol. 2020. PMID: 32163589. doi:10.1111/bjd.19024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。